Barry S. Brown, Ph.D.

Barry S. Brown, Ph.D.
Barry S. Brown, Ph.D.
Senior Research Scientist

Ph.D., Clinical Psychology, Western Reserve University
brownb@uncw.edu
Phone: 410-837-3977
Fax: 410-752-4218
Research Interests

Dr. Brown has worked in the fields of mental health, criminal justice, and substance abuse as both clinician and researcher for the past 45 years. Dr. Brown joined the staff of the newly formed National Institute on Drug Abuse (NIDA) in 1975 after first serving as clinical psychologist in State and Veterans Administration programs in Ohio, and in the federal penitentiary at Terre Haute, Indiana, as well as acting as the research director for the District of Columbia Department of Corrections, and for the DC Narcotics Treatment Administration. At NIDA he headed up its services research, treatment research, and clinical research programs, as well as developing NIDA’s intramural outpatient research facility and program in Baltimore, Maryland. Later, amidst a hail of confetti and some small arms fire, he returned to NIDA’s extramural program to head up the Institute’s outreach-based HIV prevention program which later was enacted into law on the basis of its success. After leaving NIDA, Dr. Brown joined the staff of the Social Research Center (SRC) of the Friends Research Institute in 1996 as a Senior Investigator. He also holds an adjunct appointment as professor of psychology at the University of North Carolina at Wilmington, and is a consulting scientist with the Institute of Behavioral Research at Texas Christian University. Dr. Brown sits on the editorial boards of several substance abuse journals, and is the author of over 100 articles in refereed journals as well as having written a number of book chapters and edited several books.

His work with the SRC has centered on long-standing interests in the areas of developing and testing aftercare strategies for drug treatment clients generally and for offender clients specifically; examining issues and strategies regarding the recruitment and early engagement in treatment of substance abusers; examining issues and strategies that can further our work in the prevention of HIV and other infectious disease among substance abusers; and developing and testing strategies for achieving the adoption of evidence-based treatments by drug treatment programs. To date, his extraordinarily talented colleagues at the SRC have successfully covered for him and he remains gainfully employed.

Selected Publications
Barbosa C, Dunlap LJ, Wedehase B, Mitchell SG, Schwartz RP, Dušek K, Kirk AS, Oros M, Hosler C, Gryczynski J, Brown BS (2015). Start-up costs of implementing Screening and Brief Intervention (SBI) for Adolescents (part of Economics of SBI symposium). Addiction Science and Clinical Practice. 10 (Suppl 2), O5.
Kelly SM, Brown BS, Katz EC, O’Grady KE, Mitchell SG, King S, Schwartz RP (2012). A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients. The American Journal of Drug and Alcohol Abuse. 38 (3), 233-238.
Mitchell SG, Kelly SM, Brown BS, O’Grady KE, Schwartz RP (2012). HIV sex-risk behaviors among in- versus out-of-treatment heroin-addicted adults. American Journal of Drug and Alcohol Abuse. 38 (4), 328-333.
Flynn PM, Brown BS (2011). Implementation research: Issues and prospects. Addictive Behaviors. 36(6), 566-569.
Katz EC, Brown BS, Schwartz RP, O’Grady KE, King SD, Gandhi D (2011). Transitioning opioid-dependent patients from detoxification to long-term treatment: Efficacy of intensive role induction. Drug and Alcohol Dependence. 117 (1), 24-30. [PMCID: PMC3090541].
Kelly SM, O’Grady KE, Mitchell SG, Brown BS, Schwartz RP (2011). Predictors of methadone treatment retention from a multi-site study: A survival analysis. Drug and Alcohol Dependence. 117. (2-3), 170-175. [PMCID: PMC3148301].
Schwartz RP, Kelly SM, O’Grady KE, Mitchell SG, Brown BS (2011). Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts. Drug and Alcohol Dependence. 115 (1-2), 23-29. [PMCID: PMC3059350].
Brown BS (2010). Commentary: The relationship between addiction and religion. Substance Use and Misuse. 45(14), 2380-2381.
Kelly SM, O’Grady KE, Brown BS, Mitchell SG, Schwartz RP (2010). The role of patient satisfaction in methadone treatment. American Journal of Drug and Alcohol Abuse, 36. (3), 150-154. [PMCID: PMC2938880].
Kelly SM, O’Grady KE, Schwartz RP, Peterson JA, Wilson ME, Brown BS (2010). The relationship of social support to treatment entry and engagement: The community assessment inventory. Substance Abuse. 31 (1), 43-52. [PMCID: PMC2856126].
Peterson JA, Schwartz RP, Mitchell SG, Reisinger HS, Kelly SM, O’Grady KE, Brown BS, Agar MH (2010). Why don’t out-of-treatment individuals enter methadone treatment programs? International Journal of Drug Policy. 21 36-42. [PMCID: PMC2790538].
Anglin MD, Brown BS, Dembo R, and Leukefeld C (2009). Criminality and addiction: Selected issues for future policies, practice, & research. Journal of Drug Issues. 39:89-100.
Katz EC, Schwartz RP, King SD, Highfield DA, O’Grady KE, Billings T, Gandhi D, Weintraub E, Glovinsky D, Barksdale W, Brown BS (2009). Brief v. extended buprenorphine detoxification in a community treatment program: Engagement and short-term outcomes.  American Journal of Drug and Alcohol Dependence.
Kelly SM, Schwartz RP, O’Grady KE, Mitchell SG, Reisinger HS, Peterson JA, Agar MH, Brown BS (2009). Gender differences among in- and out-of-treatment opioid-addicted individuals. American Journal of Drug and Alcohol Abuse. 35, 38-42.
Kinlock TW, Sears EA, O’Grady KE, Callaman JM, Brown BS (2009). Treatment retention and changes in motivation among drug court probationers.  Journal of Offender Rehabilitation.
Mitchell SG, Kelly SM, Brown BS, Reisinger HS, Peterson JA, Ruhf A, Agar MH, O’Grady KE Schwartz RP (2009). Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland. The American Journal on Addictions.
Mitchell SG, Kelly SM, Brown BS, Reisinger HS, Peterson JA, Ruhf A, Agar MH, Schwartz RP (2009). Incarceration and opioid withdrawal: The experiences of methadone patients and out-of-treatment heroin users.  Journal of Psychoactive Drugs.
Flynn PM, Brown BS (2008). Co-occurring disorders in substance abuse treatment: Issues and prospects. Journal of Substance Abuse Treatment. 34(1):36-47.
Peterson JP, Schacht-Reisinger H, Schwartz RP, Mitchell SG, Kelly SM, Brown BS, Agar MH (2008). Targeted sampling in drug abuse research: A review and case study.  Field Methods. 20(2), 155-170.
Reisinger HS, Schwartz RP, Mitchell SG, Peterson JA, Kelly SM, O’Grady KE, Marrari EA, Brown BS, Agar MH (2008). Premature discharge from methadone treatment: Patient perspectives. Journal of Psychoactive Drugs.
Schwartz RP, Kelly SM, O’Grady KE, Mitchell SG, Peterson JA, Reisinger HS, Agar MH, Brown BS (2008). Attitudes toward buprenorphine and methadone among opioid-dependent individuals. American Journal on Addictions. 17(5), 396-401.
Schwartz RP, Kelly SM, O’Grady KE, Peterson JA, Reisinger HS, Mitchell SG, Wilson ME, Agar MH, Brown BS (2008). In-treatment v. out-of-treatment opioid dependent adults: Drug use and criminal history. American Journal of Drug and Alcohol Abuse. 34(1), 17-28.
Katz EC, Brown BS, Schwartz RP, King SD, Weintraub E, Barksdale W (2007). Impact of role induction on long-term drug treatment outcomes. Journal of Addictive Diseases. 26, 81-90. PMID: 17595001.
Katz ES, Brown BS, Schwartz RP, King SD, Weintraub E, and Barksdale W (2007). Impact of role induction on long-term treatment outcome. Journal of Addictive Diseases. 26(2):81-90.
Brown BS (2006). Evidence-based treatment: Why, what, where, and how – Commentary. Journal of Substance Abuse Treatment. 30, 87-89.
Kinlock TW, Sears EA, O’Grady KE, Callaman JM, Brown BS (2005). The effect of motivational enhancement therapy on drug abuse treatment retention among drug court clients. Journal of Community Corrections. 15, 11-17, 27.
Brown BS, O’Grady KE, Battjes RJ, and Farrell EV (2004). Factors associated with treatment outcomes in an aftercare population. American Journal on Addictions. 13, 447-460.
Brown BS, O’Grady KE, Battjes RJ, and Katz EC (2004). The Community Assessment Inventory – Client views of supports to drug abuse treatment. Journal of Substance Abuse Treatment. 27:241-251.
Katz EC, Brown BS, Schwartz RP, Weintraub E, Barksdale W, and Robinson R (2004). Role induction: A method for enhancing early retention in outpatient drug-free treatment. Journal of Consulting and Clinical Psychology. 72, 227-234.
Brown BS, Kinlock TW, and Nurco DN (2001). Self-help initiatives to reduce the risk of relapse. In: Platt, JJ, Tims, FM, & Leukefeld, CG. Relapse and Recovery Processes in the Addictions. New Haven: Yale University Press.
Brown BS, O’Grady KE, Battjes RJ, Farrell EE, Smith NP, and Nurco DN (2001). Effectiveness of a stand-alone aftercare program for drug-involved offenders. Journal of Substance Abuse Treatment. 21:185-192.
Brown BS, O’Grady KE, Farrell EV, Flechner IS, and Nurco DN (2001). Factors associated with frequency of 12-Step attendance by drug abuse clients. American Journal of Drug and Alcohol Abuse. 27, 147-160.
Brown BS, O’Grady KE, Farrell EV, Flechner IS, and Nurco DN (2001). Factors associated with frequent and infrequent HIV testing. Substance Use and Misuse. 36, 1593-1609.
Brown BS (1998). Drug use–Chronic and relapsing or a treatable condition. Substance Use and Misuse. 33(2), 2515-2520.
Brown BS (1997). Staffing patterns and services for the war on drugs. In J Egertson, DM Fox, and AI Leshner(Eds.) Treating Drug Abusers Effectively. Blackwell Press.
Fletcher BW, Tims FM, Brown BS (1997). National treatment evaluations and the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors. 11:216-229.
Simpson DD, Joe GW, Brown BS (1997). Length of stay in treatment and follow-up outcomes in DATOS. Psychology of Addictive Behaviors. 11, 294-307.
Brown BS (1996). Policy issues and policy development in drug abuse. In BL Levin and J Petrilla (Eds.), Mental Health Services: A Public Health Perspective, Oxford Press.
Brown BS, and McLellan AT (1996). HIV/AIDS and Drug Abuse Treatment. Journal of Substance Abuse Treatment. 13 (no. 5).
Camacho LM, Brown BS, and Simpson DD (1996). Psychological dysfunction and HIV/AIDS risk behavior. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 11(2), 198-202.
Joe GW, Brown BS, and Simpson DD (1995). Psychological problems and client engagement in methadone treatment. Journal of Nervous and Mental Disease. 183(11), 704-710.
Simpson DD, Chatham LR, Brown BS (1995). The role of evaluation research in drug abuse policy. Current Directions in Psychological Science. 4(4), 123-126.
Brown BS and Needle RH (1994). Modifying the process of treatment to meet the threat of AIDS. International Journal of the Addictions. 29, 739-1752.
Brown BS, and Beschner GM (1993). Handbook on Risk of AIDS - Injection Drug Users and Sexual Partners. Wesport, Conn.: Greenwood Press.
Brown BS, and Beschner GM (1989). AIDS and HIV infection - implications for drug abuse treatment. Journal of Drug Issues. 19:141-162.
Brown BS (1985). Federal drug abuse policy and minority group issues - reflections of a participant observer. International Journal of the Addictions. 20:203-216.